Martin Shkreli (Dennis Van Tine/Sipa USA, Sipa via AP Images)

Mar­tin Shkre­li faces an­oth­er law­suit, this time from in­sur­er, al­leg­ing plans to cre­ate a mo­nop­oly for Dara­prim

The no­to­ri­ous “Phar­ma Bro” Mar­tin Shkre­li prompt­ed na­tion­al out­rage in 2015 when he and then-Tur­ing Phar­ma­ceu­ti­cals raised the price of Dara­prim, the “gold stan­dard” treat­ment …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.